COLD, FLU & COUGH NEWS AND RESEARCH
Latest Cold, Flu & Cough News and Research
%2c_3D_illustration._A_virus_transmitted_by_mosquito_and_caus_-_Kateryna_Kon_M1_0169e949c192415f987ebf3618689a4c-150x125.jpg "Disease-carrying mosquitoes fly free as health departments focus on coronavirus")
Disease-carrying mosquitoes fly free as health departments focus on coronavirus
The U.S. public health system has been starved for decades and lacks the resources necessary to confront the worst health crisis in a century. Read the investigation from KHN and The Associated Press.
Study shows how parasitic bacteria cause lesions in the skin and internal organs
Bacteria of the genus Bartonella are parasites that can be transmitted to humans via insect bites and animal scratches, resulting in an infection known as "bartonellosis."
Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection
Statins are a class of drugs often used to control high cholesterol levels in obesity. Now, a study published on the preprint server medRxiv* in July 2020 suggests that statins do not aggravate the risk of COVID-19 infection and may have a small beneficial effect in some cases.
_e081922bd08c4976b0ec52b03e525f5a-150x125.jpg "Evidence of SARS-CoV-2 placental infection in mild COVID-19")
Evidence of SARS-CoV-2 placental infection in mild COVID-19
Now, a new study published on the preprint server medRxiv* in July 2020 reveals evidence of placental infection and hypoxia, despite the lack of serious symptoms in the mother.
Earlier 'Test, Trace, Isolate' on Isle of Wight reduced COVID-19 incidence and R0
Researchers in the UK report that the incidence of new coronavirus disease 2019 (COVID-19) cases fell in the Isle of Wight following the launch of a new “Test, Trace, Isolate (TTI)” program on May 5th that included the option of using an NHS Smartphone app.
_414b4341a30447ecaa698268fda294cf-150x125.jpg "Study explains why fetuses and newborns are mostly spared by COVID-19")
Study explains why fetuses and newborns are mostly spared by COVID-19
Amid the coronavirus pandemic, it has been previously suggested that the most vulnerable individuals to developing severe coronavirus disease (COVID-19) include the elderly, those with underlying health conditions, and those who have weakened immune systems.
Buck researchers investigate ketone bodies as possible therapeutic against COVID-19
Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an aging-related disease, no matter how old they are when they get infected.
Obesity and metabolic syndrome increase risk for severe influenza, COVID-19
Metabolic syndrome increases the risk of severe disease from viral infection, according to a review of the literature performed by a team of researchers from St. Jude Graduate School of Biomedical Sciences and the University of Tennessee Health Science Center, both in Memphis.
Common FDA-approved drug may be a powerful tool in fighting COVID-19
A common drug, already approved by the Food and Drug Administration, may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.
UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia
Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial.
Nanotechnology plays major role in COVID-19 vaccine development
From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.
Anti-inflammatory medication helps fight dangerous immune response in COVID-19 patients
Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational study at Cedars-Sinai.
Cholesterol-lowering drugs show promise to lower COVID-19's threat
Could a simple drug, that has been on the market for decades, be used to treat COVID-19? A research team led by Hebrew University of Jerusalem (HU)'s Professor Yaakov Nahmias says that early research looks promising; their findings appear in this week's Cell Press' Sneak Peak.
Quest Diagnostics Health Trends study: HPV screening less likely to detect cervical cancer than cotesting
A Health Trends study from researchers at Quest Diagnostics and the University of Pittsburgh Medical Center provides new evidence that the HPV screening test is significantly less likely to detect cervical cancer and precancer than cotesting, a method which combines HPV and Pap testing using the same specimen.
BATM introduces three new diagnostic kits for COVID-19 and other respiratory illness
BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces the launch of three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses.
Proportion of healthcare-associated infections is higher than believed
One in four inpatients with influenza in a given season showed signs of having become infected during care. This is clear from a University of Gothenburg thesis about the spread of influenza in hospitals and how this problem can be remedied.
Antibodies to SARS-CoV-2 disappear within three months
The question is, does this infection confer lasting immunity? A new study published in the journal Clinical Microbiology and Infection in July 2020 appears to show that it does not, with antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disappearing within three months of infection.
_1d6309de14bd42af8252aef0dd4199d8-150x125.jpg "Certain antibodies may cause the dangerous part of COVID-19 disease")
Certain antibodies may cause the dangerous part of COVID-19 disease
A new study out of the Netherlands and published on the preprint server bioRxiv* in July 2020 discusses the commonly observed phenomenon of COVID-19 progression at 1-2 weeks from the onset of the earliest symptoms. This is ascribed to the overactivation of the inflammatory signaling cascade triggered by a hyperactive adaptive immune reaction, commonly called the cytokine storm.
_on_human_skin-Tacio_Philip-1000_63ca0542f3674714a09eca4dc8beabab-150x125.jpg "Nix gene can help develop future mosquito control techniques")
Nix gene can help develop future mosquito control techniques
Virginia Tech researchers have proven that a single gene can convert female Aedes aegypti mosquitoes into fertile male mosquitoes and identified a gene needed for male mosquito flight.
"Winter is coming," warn UK COVID-19 experts
The famous line from "Game of Thrones" about approaching dangers this winter may prove to be accurate, say, scientists in a new report. The researchers state that a second wave of infection could hit the United Kingdom this winter, and this would be worse than the first wave taking as many as 120,000 lives.
No hay comentarios:
Publicar un comentario